New drug test hope
AN over-the-counter supplement is being tested as a cheap, safe way to treat a wide range of the most common age and lifestyle-related diseases.
Instead of using medication for a single risk factor or disease pathway, Monash University researchers are testing whether carnosine can target mechanisms that drive several chronic diseases.
More than 2000 studies have shown its effects on type 2 diabetes, cardiovascular disease, dementia, cancer and delaying ageing. The first human clinical trials will measure its effects on body fat, blood pressure, blood glucose, sleep, depression and cognition.